+1 347 708 0418
Point-of-care Molecular Diagnostic Solution market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Point-of-care Molecular Diagnostic Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Assays & kits
Instruments & Analyzers
Software & Services
Segment by Application
PhysiciansÂ’ Offices
Hospitals & ICUs
Research Institutes
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Cepheid, Inc.
Danaher Corporation
Johnson and Johnson
Bayer Healthcare
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Assays & kits
1.2.3 Instruments & Analyzers
1.2.4 Software & Services
1.3 Market by Application
1.3.1 Global Point-of-care Molecular Diagnostic Solution Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 PhysiciansÂ’ Offices
1.3.3 Hospitals & ICUs
1.3.4 Research Institutes
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Molecular Diagnostic Solution Market Perspective (2017-2028)
2.2 Point-of-care Molecular Diagnostic Solution Growth Trends by Region
2.2.1 Point-of-care Molecular Diagnostic Solution Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Point-of-care Molecular Diagnostic Solution Historic Market Size by Region (2017-2022)
2.2.3 Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Region (2023-2028)
2.3 Point-of-care Molecular Diagnostic Solution Market Dynamics
2.3.1 Point-of-care Molecular Diagnostic Solution Industry Trends
2.3.2 Point-of-care Molecular Diagnostic Solution Market Drivers
2.3.3 Point-of-care Molecular Diagnostic Solution Market Challenges
2.3.4 Point-of-care Molecular Diagnostic Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Molecular Diagnostic Solution Players by Revenue
3.1.1 Global Top Point-of-care Molecular Diagnostic Solution Players by Revenue (2017-2022)
3.1.2 Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Players (2017-2022)
3.2 Global Point-of-care Molecular Diagnostic Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Molecular Diagnostic Solution Revenue
3.4 Global Point-of-care Molecular Diagnostic Solution Market Concentration Ratio
3.4.1 Global Point-of-care Molecular Diagnostic Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Molecular Diagnostic Solution Revenue in 2021
3.5 Point-of-care Molecular Diagnostic Solution Key Players Head office and Area Served
3.6 Key Players Point-of-care Molecular Diagnostic Solution Product Solution and Service
3.7 Date of Enter into Point-of-care Molecular Diagnostic Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Molecular Diagnostic Solution Breakdown Data by Type
4.1 Global Point-of-care Molecular Diagnostic Solution Historic Market Size by Type (2017-2022)
4.2 Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Type (2023-2028)
5 Point-of-care Molecular Diagnostic Solution Breakdown Data by Application
5.1 Global Point-of-care Molecular Diagnostic Solution Historic Market Size by Application (2017-2022)
5.2 Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
6.2 North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
6.3 North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
7.2 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
7.3 Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
8.2 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
8.3 Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
9.2 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
9.3 Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size (2017-2028)
10.2 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022)
10.3 Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Introduction
11.1.4 Abbott Laboratories Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 F. Hoffmann-La Roche AG
11.2.1 F. Hoffmann-La Roche AG Company Detail
11.2.2 F. Hoffmann-La Roche AG Business Overview
11.2.3 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Introduction
11.2.4 F. Hoffmann-La Roche AG Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.2.5 F. Hoffmann-La Roche AG Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Detail
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Introduction
11.3.4 Becton, Dickinson and Company Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 BioMerieux
11.4.1 BioMerieux Company Detail
11.4.2 BioMerieux Business Overview
11.4.3 BioMerieux Point-of-care Molecular Diagnostic Solution Introduction
11.4.4 BioMerieux Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.4.5 BioMerieux Recent Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Detail
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.5.5 Bio-Rad Laboratories, Inc. Recent Development
11.6 Cepheid, Inc.
11.6.1 Cepheid, Inc. Company Detail
11.6.2 Cepheid, Inc. Business Overview
11.6.3 Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Introduction
11.6.4 Cepheid, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.6.5 Cepheid, Inc. Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Detail
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Point-of-care Molecular Diagnostic Solution Introduction
11.7.4 Danaher Corporation Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.7.5 Danaher Corporation Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Detail
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Introduction
11.8.4 Johnson and Johnson Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.8.5 Johnson and Johnson Recent Development
11.9 Bayer Healthcare
11.9.1 Bayer Healthcare Company Detail
11.9.2 Bayer Healthcare Business Overview
11.9.3 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Introduction
11.9.4 Bayer Healthcare Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
11.9.5 Bayer Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Assays & kits
Table 3. Key Players of Instruments & Analyzers
Table 4. Key Players of Software & Services
Table 5. Global Point-of-care Molecular Diagnostic Solution Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Point-of-care Molecular Diagnostic Solution Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Point-of-care Molecular Diagnostic Solution Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Point-of-care Molecular Diagnostic Solution Market Share by Region (2017-2022)
Table 9. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Point-of-care Molecular Diagnostic Solution Market Share by Region (2023-2028)
Table 11. Point-of-care Molecular Diagnostic Solution Market Trends
Table 12. Point-of-care Molecular Diagnostic Solution Market Drivers
Table 13. Point-of-care Molecular Diagnostic Solution Market Challenges
Table 14. Point-of-care Molecular Diagnostic Solution Market Restraints
Table 15. Global Point-of-care Molecular Diagnostic Solution Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Point-of-care Molecular Diagnostic Solution Market Share by Players (2017-2022)
Table 17. Global Top Point-of-care Molecular Diagnostic Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Molecular Diagnostic Solution as of 2021)
Table 18. Ranking of Global Top Point-of-care Molecular Diagnostic Solution Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Point-of-care Molecular Diagnostic Solution Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Point-of-care Molecular Diagnostic Solution Product Solution and Service
Table 22. Date of Enter into Point-of-care Molecular Diagnostic Solution Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Point-of-care Molecular Diagnostic Solution Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Type (2017-2022)
Table 26. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Type (2023-2028)
Table 28. Global Point-of-care Molecular Diagnostic Solution Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Application (2017-2022)
Table 30. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Application (2023-2028)
Table 32. North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2023-2028) & (US$ Million)
Table 42. Abbott Laboratories Company Detail
Table 43. Abbott Laboratories Business Overview
Table 44. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product
Table 45. Abbott Laboratories Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 46. Abbott Laboratories Recent Development
Table 47. F. Hoffmann-La Roche AG Company Detail
Table 48. F. Hoffmann-La Roche AG Business Overview
Table 49. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product
Table 50. F. Hoffmann-La Roche AG Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 51. F. Hoffmann-La Roche AG Recent Development
Table 52. Becton, Dickinson and Company Company Detail
Table 53. Becton, Dickinson and Company Business Overview
Table 54. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Product
Table 55. Becton, Dickinson and Company Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 56. Becton, Dickinson and Company Recent Development
Table 57. BioMerieux Company Detail
Table 58. BioMerieux Business Overview
Table 59. BioMerieux Point-of-care Molecular Diagnostic Solution Product
Table 60. BioMerieux Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 61. BioMerieux Recent Development
Table 62. Bio-Rad Laboratories, Inc. Company Detail
Table 63. Bio-Rad Laboratories, Inc. Business Overview
Table 64. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Product
Table 65. Bio-Rad Laboratories, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 66. Bio-Rad Laboratories, Inc. Recent Development
Table 67. Cepheid, Inc. Company Detail
Table 68. Cepheid, Inc. Business Overview
Table 69. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Product
Table 70. Cepheid, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 71. Cepheid, Inc. Recent Development
Table 72. Danaher Corporation Company Detail
Table 73. Danaher Corporation Business Overview
Table 74. Danaher Corporation Point-of-care Molecular Diagnostic Solution Product
Table 75. Danaher Corporation Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 76. Danaher Corporation Recent Development
Table 77. Johnson and Johnson Company Detail
Table 78. Johnson and Johnson Business Overview
Table 79. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product
Table 80. Johnson and Johnson Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 81. Johnson and Johnson Recent Development
Table 82. Bayer Healthcare Company Detail
Table 83. Bayer Healthcare Business Overview
Table 84. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product
Table 85. Bayer Healthcare Revenue in Point-of-care Molecular Diagnostic Solution Business (2017-2022) & (US$ Million)
Table 86. Bayer Healthcare Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-care Molecular Diagnostic Solution Market Share by Type: 2021 VS 2028
Figure 2. Assays & kits Features
Figure 3. Instruments & Analyzers Features
Figure 4. Software & Services Features
Figure 5. Global Point-of-care Molecular Diagnostic Solution Market Share by Application in 2021 & 2028
Figure 6. PhysiciansÂ’ Offices Case Studies
Figure 7. Hospitals & ICUs Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Other End Users Case Studies
Figure 10. Point-of-care Molecular Diagnostic Solution Report Years Considered
Figure 11. Global Point-of-care Molecular Diagnostic Solution Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Point-of-care Molecular Diagnostic Solution Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Point-of-care Molecular Diagnostic Solution Market Share by Region: 2021 VS 2028
Figure 14. Global Point-of-care Molecular Diagnostic Solution Market Share by Players in 2021
Figure 15. Global Top Point-of-care Molecular Diagnostic Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Molecular Diagnostic Solution as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Point-of-care Molecular Diagnostic Solution Revenue in 2021
Figure 17. North America Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Point-of-care Molecular Diagnostic Solution Market Share by Country (2017-2028)
Figure 19. United States Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Point-of-care Molecular Diagnostic Solution Market Share by Country (2017-2028)
Figure 23. Germany Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Share by Region (2017-2028)
Figure 31. China Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Point-of-care Molecular Diagnostic Solution Market Share by Country (2017-2028)
Figure 39. Mexico Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Share by Country (2017-2028)
Figure 43. Turkey Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 46. F. Hoffmann-La Roche AG Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 47. Becton, Dickinson and Company Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 48. BioMerieux Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 50. Cepheid, Inc. Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 51. Danaher Corporation Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 52. Johnson and Johnson Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 53. Bayer Healthcare Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Buy
